Stella M. Sung
Chief Executive Officer at Aegea Biotechnologies, Inc.
Profile
Dr. Stella M.
Sung is a Managing Director at Pearl Street Venture Funds.
She brings over a decade of experience in the healthcare sector to Pearl Street Venture Funds.
Prior to joining Coastview Capital, she was a General Partner at Oxford Bioscience Partners.
She has eight years of direct experience in life science venture capital and has led venture rounds of financing for six transactions, co-founded two biotechnology companies, served on 6 Boards of Directors and served as Chairman of the Board for four biotechnology companies.
Previously, she focused on life science and health care investments at Advent International, a global private equity firm that has raised over $6 billion in cumulative capital to date.
Dr. Sung received her B.S.
in chemistry from The Ohio State University and her Ph.D.
in chemistry from Harvard University, where she was a National Science Foundation Pre-Doctoral Fellow.
Stella M. Sung active positions
| Companies | Position | Start |
|---|---|---|
Pearl Street Venture Funds
 Pearl Street Venture Funds Investment ManagersFinance Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana. | Private Equity Investor | 2004-04-30 |
Aegea Biotechnologies, Inc.
 Aegea Biotechnologies, Inc. Medical/Nursing ServicesHealth Services Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation. | Chief Executive Officer | 2019-08-31 |
Former positions of Stella M. Sung
| Companies | Position | End |
|---|---|---|
| ImmunoActiva, Inc. | Founder | 2019-08-31 |
| TAURIGA SCIENCES, INC. | Chief Executive Officer | 2015-07-12 |
| TAURIGA SCIENCES, INC. | Chief Executive Officer | 2014-12-31 |
Coastview Capital LLC
 Coastview Capital LLC Investment ManagersFinance Founded in 2001, Coastview Capital LLC is a venture capital firm headquartered in Los Angeles | Private Equity Investor | 2005-12-30 |
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Corporate Officer/Principal | - |
Training of Stella M. Sung
| Harvard University | Doctorate Degree |
| The Ohio State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TAURIGA SCIENCES, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Advent International LP
 Advent International LP Investment ManagersFinance Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts. | Finance |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Coastview Capital LLC
Coastview Capital LLC Investment ManagersFinance Founded in 2001, Coastview Capital LLC is a venture capital firm headquartered in Los Angeles | Finance |
Pearl Street Venture Funds
Pearl Street Venture Funds Investment ManagersFinance Pearl Street Venture Funds (Pearl Street) is a venture capital firm founded in 2003 by Tim J. Tichenor. The firm is headquartered in Indianapolis, Indiana. | Finance |
AVITA Medical Pty Ltd.
AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Health Technology |
Aegea Biotechnologies, Inc.
Aegea Biotechnologies, Inc. Medical/Nursing ServicesHealth Services Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation. | Health Services |
| ImmunoActiva, Inc. |
- Stock Market
- Insiders
- Stella M. Sung
